Stockreport

Seattle Genetics wins early U.S. approval for $18,500 breast cancer therapy [Reuters]

Seagen Inc.  (SGEN) 
Last seagen inc. earnings: 4/30 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.seattlegenetics.com
PDF Seattle Genetics wins early U.S. approval for $18,500 breast cancer therapy April 17 (Reuters) - Seattle Genetics Inc’s add-on therapy for a type of breast cancer that h [Read more]